Disease relevance of Pistacia

• As part of screening aimed at the selection of novel antimycotic compounds of vegetable origin, leaf extracts of Camellia sinensis L., Cupressus sempervirens L. and Pistacia lentiscus L. and the seed extract of Glycine soja Sieb. et Zucc. were tested against yeast and yeast-like species implicated in human mycoses [1].

High impact information on Pistacia

• Antiatherogenic effect of Pistacia lentiscus via GSH restoration and downregulation of CD36 mRNA expression [2].
• In order to determine whether further oxidation of carbon 3 affects anti-inflammatory activity in mice, different tests were carried out on oleanolic acid and its 3-oxo-analogue oleanonic acid, which was obtained from Pistacia terebinthus galls [3].
• Chemical composition and antimicrobial activity of the essential oils of Pistacia lentiscus var. chia [4].
• Simulation results showed that measurements based on retail samples (for which the maximum number of increments is constrained by cost) may produce fit-for-purpose results for the measurement of ochratoxin A in dried fruit, but are unlikely to do so for the measurement of aflatoxin B1 in pistachio nuts [5].
• (Pistacia terebinthus L. var. palaestina (Boiss.) Engl.) is a medicinal and foodstuff plant [6].

Associations of Pistacia with chemical compounds

• Structures of 4-aryl-coumarin (neoflavone) dimers isolated from Pistacia chinensis BUNGE and their estrogen-like activity [7].
• Pistafolia A is a novel gallotannin isolated from the leaf extract of Pistacia weinmannifolia [8].
• Pharmacological actions of a new procyanidin polymer from Pistacia lentiscus L [9].
• Isolation and hypotensive activity of a polymeric procyanidin fraction from Pistacia lentiscus L [10].
• Identification and quantification of galloyl derivatives, flavonoid glycosides and anthocyanins in leaves of Pistacia lentiscus L [11].

Gene context of Pistacia

• Antioxidant properties of two gallotannins isolated from the leaves of Pistacia weinmannifolia [12].
• Fifty-eight atopic and nine non-atopic volunteers, all residents of the Tel Aviv metropolitan area, Israel, were skin tested with extracts made from filtered pollen of Pistacia atlantica, P. lentiscus, P. palaestina and P. vera [13].

Analytical, diagnostic and therapeutic context of Pistacia

• Comparison with contemporary resins has facilitated the partial identification of the material in this important artefact as a triterpenoid-rich material, which is closely similar to the Pistacia species [14].

References